Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biomarkers and Early Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04342923
What this trial is testing

Early POstoperative BIomarkers in PancreatoDuodenectomy: a Spanish Nationwide Study

Who this might be right for
Pancreaticoduodenectomy
Hospital Clínico Universitario de Valladolid 525
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Not applicableLooking for participantsNCT07035691
What this trial is testing

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

Who this might be right for
Colorectal CarcinomaPolypColorectal Adenoma
Queen Mary University of London 582
Not applicableUnknownNCT03286036
What this trial is testing

Clinical and Molecular Staging of Lung Cancer Stages I and IIp

Who this might be right for
Lung Cancer
Corporacion Parc Tauli 200
Not applicableUnknownNCT01286233
What this trial is testing

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Who this might be right for
Breast CancerDepressionFatigue+1 more
NSABP Foundation Inc 394
Not applicableStudy completedNCT02352506
What this trial is testing

Serum MIF in Acute Kidney Injury

Who this might be right for
Acute Kidney Injury
Medical University of Vienna 500
Not applicableUnknownNCT06256887
What this trial is testing

Sleep Spindles Organization as an Early Neural Marker of Neuromotor Outcome

Who this might be right for
EEG Sleep SpindlesMotor OutcomeCerebral Palsy+1 more
IRCCS Fondazione Stella Maris 80
Not applicableStudy completedNCT00467311
What this trial is testing

Cystatin C as an Early Marker of Contrast-Medium Nephropathy in Cardiac Catheterization Patients

Who this might be right for
Contrast Induced NephropathyAcute Renal Failure
National Heart Institute, Mexico 66
Not applicableActive Not RecruitingNCT06979921
What this trial is testing

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

Who this might be right for
Cancer
The First Affiliated Hospital with Nanjing Medical University 496
Not applicableNot Yet RecruitingNCT07096752
What this trial is testing

Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric Cancer

Who this might be right for
Gastric Cancer (Diagnosis)
Shanghai Zhongshan Hospital 1,200
Not applicableStudy completedNCT03912012
What this trial is testing

Pilot Study DiaDEP

Who this might be right for
Diabetes Mellitus, Type 1Type1diabetes
Hospices Civils de Lyon 23
Not applicableStudy completedNCT01902316
What this trial is testing

Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Beijing Institute of Technology 389
Not applicableNot Yet RecruitingNCT07072052
What this trial is testing

Oxford Luteal Dysfunction and Placental Insufficiency Study

Who this might be right for
Pre-eclampsia
University of Oxford 360
Post-approval studies (Phase 4)Study completedNCT04774926
What this trial is testing

Study of Innovative Multimodal Imaging Biomarkers to Predict Anatomical Outcome in Naive Patients With wAMD Treated With Brolucizumab.

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 122
Not applicableUnknownNCT05298072
What this trial is testing

Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast CancerHeart Failure
University Hospital, Essen 180
Not applicableUnknownNCT05700370
What this trial is testing

MyProstateScore Equivalency With and Without DRE

Who this might be right for
Prostate Cancer
LynxDx 800
Not applicableUnknownNCT05594966
What this trial is testing

Neuroimaging Combining Biomarkers for Identifying Long-term Cognitive Dysfunction and Delirium

Who this might be right for
Postoperative Cognitive DysfunctionPostoperative DeliriumCerebral Small Vessel Diseases+1 more
RenJi Hospital 211
Not applicableUnknownNCT06213766
What this trial is testing

Spatial and Ocular Trajectories for the Early Diagnosis of Alzheimer's Disease.

Who this might be right for
Alzheimer DiseaseAging
Hospices Civils de Lyon 250
Testing effectiveness (Phase 2)Study completedNCT01815242
What this trial is testing

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 336
Very early researchStudy completedNCT03197389
What this trial is testing

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerHormone Receptor Negative Neoplasm
Universitaire Ziekenhuizen KU Leuven 54
Next Page